CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-01 | Li Dean Y Executive VP & President, MRL | Option exercise | +1,062 | $115.47 | $123K | 20,995.43 |
| 2023-05-01 | Li Dean Y Executive VP & President, MRL | Shares withheld for taxes | −524 | $115.47 | $61K | 20,471.43 |
| 2023-05-01 | Li Dean Y Executive VP & President, MRL | Option exercise · Restricted Stock Unit | −1,062 | 0 | ||
| 2023-05-01 | Litchfield Caroline EVP & CFO | Option exercise | +866 | $115.47 | $100K | 32,118.27 |
| 2023-05-01 | Litchfield Caroline EVP & CFO | Shares withheld for taxes | −427 | $115.47 | $49K | 31,691.27 |
| 2023-05-01 | Litchfield Caroline EVP & CFO | Option exercise · Restricted Stock Unit | −866 | 0 | ||
| 2023-05-01 | Oosthuizen Johannes Jacobus President, U.S. Market | Option exercise | +866 | $115.47 | $100K | 19,726.75 |
| 2023-05-01 | Oosthuizen Johannes Jacobus President, U.S. Market | Shares withheld for taxes | −427 | $115.47 | $49K | 19,299.75 |
| 2023-05-01 | Oosthuizen Johannes Jacobus President, U.S. Market | Option exercise · Restricted Stock Unit | −866 | 0 | ||
| 2023-05-01 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Option exercise | +643 | $115.47 | $74K | 4,375.69 |
| 2023-05-01 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Shares withheld for taxes | −221 | $115.47 | $26K | 4,154.69 |
| 2023-05-01 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Option exercise · Restricted Stock Unit | −643 | 0 | ||
| 2023-05-01 | Klobuchar Michael A EVP - Chief Strategy Officer | Option exercise | +866 | $115.47 | $100K | 18,901.46 |
| 2023-05-01 | Klobuchar Michael A EVP - Chief Strategy Officer | Shares withheld for taxes | −427 | $115.47 | $49K | 18,591 |
| 2023-05-01 | Klobuchar Michael A EVP - Chief Strategy Officer | Option exercise · Restricted Stock Unit | −866 | 0 | ||
| 2023-05-01 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise | +75,436 | $56.04 | $4.2M | 229,928.85 |
| 2023-05-01 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Sale | −75,436 | $116.03 | $8.8M | 154,492.85 |
| 2023-05-01 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise · Stock Option (Right to Buy) | −75,436 | 0 | ||
| 2023-04-28 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise | +66,163 | $62.07 | $4.1M | 220,655.85 |
| 2023-04-28 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Sale | −66,163 | $115.00 | $7.6M | 154,492.85 |
Page 25 of 29 · 572 trades